Knowledge Center

Membership Resources


Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.

After making your filter selections, please scroll down to see results.

Filters
Clear All
Results 388
Infographics

Patients Experience with Statin Therapy: Findings of the STatin Adverse Treatment Experience (STATE) Patient Survey*

Read More |
Articles

Statin Use in Chronic Hepatitis C Infection, NAFLD/NASH, Cirrhosis and Hepatocellular Carcinoma

Case Presentation: G.S. is a 60-year-old male referred for cholesterol treatment complicated by background liver disease. He has a history of schizophrenia and chronic hepatitis C virus (HCV) diagnosed in 2016. He is asymptomatic and…

Read More |
Articles

Getting the e-Patient Equipped and Engaged

Patients often search the internet for medical answers and solutions before talking to their healthcare provider (HCP). This article provides practice pearls for conversing with…

Read More |
Articles

Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association

Lipoprotein(a) [Lp(a)] is a well-recognized, independent risk factor for atherosclerotic cardiovascular disease, with elevated levels estimated to be prevalent in 20% of the population.

Read More |
Articles

Myths and Misunderstandings – The Rationale and Evidence for the Screening and Treatment of Pediatric Dyslipidemia

Landmark autopsy studies have demonstrated that atherosclerosis begins in youth and is associated with numerous cardiovascular disease (CVD) risk factors, including dyslipidemia.(1,2) Having fewer cardiometabolic…

Read More |
Articles

Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit: A consensus statement from the National Lipid Association

Acquisition costs and cost-effectiveness have limited access and recommendations to use proprotein convertase subtilisin/kexin type 9 (PCSK9)–inhibiting monoclonal antibodies (mAbs).

Read More |
Infographics

Motivational Interviewing to Promote Behavior Change

Read More |
Articles

Best Biomarkers for Inflammation

Atherosclerosis is widely recognized as a chronic inflammatory disorder. Therapies with anti-inflammatory effects in patients with an increased inflammatory status can reduce cardiovascular events, as…

Read More |